CD4 and neoplasm: By comparing to Groups A (P = 0.050), B (P = 0.049), and PBS-treatment (P = 0.006), Group C demonstrated the lowest percentage of tumor-infiltrating CD3+CD4+Foxp3+ Treg cells in total CD4+ TILs (Fig. 4B, right panel.